• Citer

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

par Awada, Ahmad ;Biganzoli, Laura ;Cufer, T;Beex, Louk;Lohrisch, C;Batter, V;Hamilton, Andrew;Nooij, Marianne;Piccart-Gebhart, Martine
Référence European journal of cancer, 38, 6, page (773-778)
Publication Publié, 2002-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.
Auteur:	Awada, Ahmad; Biganzoli, Laura; Cufer, T; Beex, Louk; Lohrisch, C; Batter, V; Hamilton, Andrew; Nooij, Marianne; Piccart-Gebhart, Martine
Informations sur la publication:	European journal of cancer, 38, 6, page (773-778)
Statut de publication:	Publié, 2002-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antibiotics, Antineoplastic -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy
	Bridged Compounds -- administration & dosage
	Deoxycytidine -- administration & dosage
	Deoxycytidine -- adverse effects
	Deoxycytidine -- analogs & derivatives
	Drug Resistance, Neoplasm
	Female
	Fluorouracil -- administration & dosage
	Fluorouracil -- adverse effects
	Humans
	Infusions, Intravenous
	Middle Aged
	Neoplasm Metastasis
	Taxoids
Note générale:	Clinical Trial
	Clinical Trial, Phase I
	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:pii/S0959804901004270
	info:pmid/11937310